AN2 Thereapeutics Inc.
13F holders, Q2 2025 (June 30)1holders
$1.06avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding AN2 Thereapeutics Inc. in their 13F filings. The largest holder was Aldebaran Capital, LLC ($427K).
- Company
- AN2 Thereapeutics Inc.
- CUSIP
- 373261056
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $427K |
| Exits | 0 | $0 |
Ownership 1 holders
| Aldebaran Capital, LLC | 0.42% | New | 402,754 | $427K |
"% of holder's portfolio" is AN2 THEREAPEUTICS INC's weight in each manager's 13F, not the share of AN2 Thereapeutics Inc. the manager owns.